Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. DAL
9. TMUS
10. VZ

Go back to Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 12c

Vanda Pharmaceuticals (VNDA) Applications for HETLIOZ Accepted by FDA for Priority Review

August 3, 2020 7:05 AM EDT

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review Vanda's applications for Smith-Magenis Syndrome (SMS). The applications include a Supplemental New Drug Application (sNDA) for HETLIOZ® capsules and a New Drug... More